Project Grant 2622634
- Federal Grant Award Summary The University of Minnesota's Office of Sponsored Projects Administration received a $492,931 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective April 1, 2026, with completion targeted for January 31, 2031. This five-year research initiative focuses on developing cell context-aware multiplexed assays of variant effect (MAVE) to advance synthetic...
- Federal Project Grant Award Summary The National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) awarded $346,497 to the University of Michigan (Regents of the University of Michigan) on July 15, 2026, for a collaborative U.S.-United Kingdom research initiative focused on engineering novel protein-based synthetic cells. The project, which operates through June 30, 2029, will develop programmable, cell-sized protein structures derived from bacterial carboxysome building...
- Federal Project Grant Award Summary The National Science Foundation's Division of Molecular and Cellular Biosciences awarded $427,615 to the Regents of the University of Michigan (effective August 1, 2026, through July 31, 2029) under the Biological Sciences program (CFDA 47.074) to support collaborative research on epigenetic silencing mechanisms. The primary deliverable is fundamental scientific research investigating how intrinsically disordered regions (IDRs) of proteins regulate the...
- Federal Grant Award Summary The National Science Foundation (NSF) Division of Materials Research awarded $285,773 through the Mathematical and Physical Sciences (CFDA 47.049) program to the University of Minnesota's Office of Sponsored Projects Administration for a three-year project running from October 1, 2025 through September 30, 2028. The project focuses on experimental investigation of microscopic dynamics in bacterial turbulence as a model system for studying emergent collective...
- Federal Project Grant Award Summary The National Science Foundation (NSF) Division of Materials Research awarded $495,000 through the Mathematical and Physical Sciences program (CFDA 47.049) to the Regents of the University of Minnesota, effective August 1, 2025, through July 31, 2028. This project grant supports fundamental research focused on the development of telechelic polyolefins—functional polyethylene and polypropylene derivatives with enhanced chemical properties. The research aims to...
- Federal Grant Award Summary The National Science Foundation (NSF) awarded a $250,000 Project Grant under the Biological Sciences program (CFDA 47.074) to the University of Colorado, effective July 1, 2026 through June 30, 2027. The project, "A Standard Enabled Synthetic Biology Workflow to Produce AI-Ready Data," addresses critical gaps in synthetic biology by developing standardized, machine-accessible experimental data and metadata workflows. The primary deliverables include...
- Federal Project Grant Award Summary The National Science Foundation's Division of Molecular and Cellular Biosciences awarded $750,000 on April 15, 2025, under the Biological Sciences program (CFDA 47.074) to The Research Foundation For The State University Of New York at the University at Albany to develop manufacturable three-dimensional (3D) mammalian cell culture systems with integrated sensing technologies, with completion targeted for March 31, 2029. The primary research deliverables...
- Federal Grant Award Summary The Regents of the University of Minnesota received a $220,000 Project Grant award from the National Science Foundation's Division of Information and Intelligent Systems (Computer and Information Science and Engineering program, CFDA 47.070) effective August 1, 2025, through July 31, 2027. This collaborative research initiative will develop generative artificial intelligence (AI) methodologies and computational tools designed to accelerate drug discovery and...
- Federal Grant Award Summary The National Science Foundation (NSF) Division of Chemical, Bioengineering, Environmental, and Transport Systems awarded $349,772 to the Regents of the University of Minnesota under the Engineering program (CFDA 47.041) to conduct collaborative research on catalysis mechanisms. The project, which commenced on September 15, 2025, and will conclude on August 31, 2028, delivers research services focused on understanding how co-adsorbates affect carbon monoxide (CO) and...
- Federal Project Grant Summary The National Science Foundation (NSF) Division of Chemistry awarded a $600,000 project grant to New York University (NYU) and NYU Langone Health, effective September 1, 2025, through August 31, 2028, under the Mathematical and Physical Sciences (CFDA 47.049) program. Led by Dr. Oded Regev and Dr. Jef Boeke, the project develops PolySnap-Seq, a novel experimental methodology to determine the spatial organization and positioning of ribosomes along individual RNA...
The National Science Foundation (NSF) awarded $195,526 to the Regents of the University of Minnesota under the Biological Sciences program (CFDA 47.074) for research addressing reproducibility challenges in cell-free protein synthesis systems. The project, initiated September 1, 2026, with completion targeted for August 31, 2027, will develop a comprehensive benchmarking framework and minimal information reporting standard for Protein Expression using Recombinantly Expressed Elements (PURE), a defined cell-free protein synthesis platform. The research will create diagnostic tools and standardized metrics to replace current limited benchmarking approaches, thereby reducing batch-to-batch and laboratory-to-laboratory variability that currently hinders reproducibility and broader adoption of PURE systems across the biotechnology and synthetic biology research communities. This foundational research directly supports NSF's strategic priorities in artificial intelligence, advanced manufacturing, and biotechnology by establishing data-driven design principles for cell-free protein synthesis systems. By improving the accessibility, predictability, and characterization of PURE systems, the project will accelerate development in synthetic cell engineering and precision biomanufacturing applications. The deliverables will include ontological frameworks, standardized reporting protocols, and rigorous benchmarking methodologies that enable more rational system design and facilitate cross-laboratory reproducibility—critical infrastructure for advancing synthetic biology research and emerging synthetic cell technologies with potential applications in medicine and industrial biomanufacturing.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $195.5k | 6/17/26 |